type here...

CATEGORIES

Healthcare

LATEST

1...383940...75Page 39 of 75

TRENDING

EDITORS CHOICE

Voluntary Recall: Two Lots of NP Thyroid® Tablets, Due to Sub Potency

Medika Life -
Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.

Patient Engagement is a Pointless Pursuit

Robert Turner, Founding Editor -
To suggest patients can influence the machine that drives modern healthcare is naïve and indicative of a flawed understanding of the realities of the industry

Healthcare Chart Notes Set the Stage for Dangerously Skewed Negative Patient Profiles

Pat Farrell PhD -
Careless use of biased language in Healthcare Chart notes gives life to skewed beliefs about patients and the state of their mental and physical health.

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories